Say Goodbye to Daily Statins? Breakthrough Gene Therapy 'VERVE-102' Cuts Bad Cholesterol by 62% With Just One IV Injection

Cardiovascular diseases remain one of the leading causes of mortality worldwide, claiming millions of lives annually across the UK, US, and India. Millions of patients rely on daily statins to manage elevated LDL (bad) cholesterol, yet adherence remains a persistent hurdle due to side effects like muscle pain or the sheer fatigue of lifelong daily medication.